Biotech Valuation Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biotech Valuation

CRSP 52.51

+2.7%

Nov 14 9:30 AM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: scott_jiminez who wrote (5546)	1/25/2002 12:39:53 AM
From: RCMac	Read Replies (1) of 52153

Peter challenged you to name me another biotech that [like ARIA] went from $0.50 to $50 - that's a 100x rise from trough to peak, without much in the way of actual progress to justify a rise. You respond, with the spurious air that's it's a full answer during the same period: - AFFX: went from 8 to 150 [19X, not 100X] - CRA: went from 7 to 250 [36X, not 100X] - CRGN: went from 2 to 125 [62X, not 100X] - GENE: went from 5 to 80 [16X, not 100X] - GLGC: went from 3 to 150 [50X, not 100X] - HYSQ: went from 4 to 130 [32X, not 100X] and on and on and on…. [bracketed figures added] Seems like this proves Peter's point. It also suggests that you have some trouble judging what's hype and what isn't.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next